| Dr John Thornton Foust, MD | |
|
800 Oak Ridge Tpke, Building A, Ste 600, Oak Ridge, TN 37830-6957 | |
| (865) 444-3050 | |
| (865) 544-1861 |
| Full Name | Dr John Thornton Foust |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 39 Years |
| Location | 800 Oak Ridge Tpke, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205834835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD017405 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Leconte Medical Center | Sevierville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health System, Inc. | 5294646378 | 526 |
News Archive
A surprise discovery - that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice - raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
A review of dozens of studies by researchers at Oregon Health & Science University and Oregon State University suggests that people may shed virus for prolonged periods, but those with mild or no symptoms may be infectious for no more than about 10 days.
Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".
Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
› Verified 6 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
A surprise discovery - that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice - raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
A review of dozens of studies by researchers at Oregon Health & Science University and Oregon State University suggests that people may shed virus for prolonged periods, but those with mild or no symptoms may be infectious for no more than about 10 days.
Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".
Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
› Verified 6 days ago
| Entity Name | Thompson Oncology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619975737 PECOS PAC ID: 0941246771 Enrollment ID: O20050701000647 |
News Archive
A surprise discovery - that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice - raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
A review of dozens of studies by researchers at Oregon Health & Science University and Oregon State University suggests that people may shed virus for prolonged periods, but those with mild or no symptoms may be infectious for no more than about 10 days.
Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".
Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Thornton Foust, MD 900 E Hill Ave, Suite 230, Knoxville, TN 37915-2566 Ph: (865) 862-0998 | Dr John Thornton Foust, MD 800 Oak Ridge Tpke, Building A, Ste 600, Oak Ridge, TN 37830-6957 Ph: (865) 444-3050 |
News Archive
A surprise discovery - that calorie-burning brown fat can be produced experimentally from muscle precursor cells in mice - raises the prospect of new ways to fight obesity and overweight, say scientists from Dana-Farber Cancer Institute.
A review of dozens of studies by researchers at Oregon Health & Science University and Oregon State University suggests that people may shed virus for prolonged periods, but those with mild or no symptoms may be infectious for no more than about 10 days.
Lancet Neurology, a prestigious journal in its domain, publishes in its last issue, an article entitled "Pitolisant versus placebo and modafinil in patients with narcolepsy: a double-blind randomised trial" authored by Y. Dauvilliers and others from the HARMONY I study group which proposes a novel treatment for this orphan disease. It is accompanied by a Commentary entitled "A need for new treatments in narcolepsy".
Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
› Verified 6 days ago
Chukwuma Umunakwe, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 202-841-5854 | |
Dr. Michael Roger Thompson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 New York Ave, Suite 200, Oak Ridge, TN 37830 Phone: 865-835-5400 Fax: 865-835-5401 | |
Andrew W Dake, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 Oak Ridge Turnpike, Suite A-402, Oak Ridge, TN 37830 Phone: 865-637-8812 Fax: 865-824-4886 | |
Aaron Joshua Smyth, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-483-3172 Fax: 865-483-8689 | |
Daniel James Gavin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-835-1000 Fax: 865-539-8008 | |
Helen Susan Bidawid, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-481-1000 | |
Victor W Mclaughlin, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 80 Vermont Ave, Oak Ridge, TN 37830 Phone: 865-482-4078 Fax: 865-482-4960 |